Enteris BioPharma has launched operations for its oral peptide delivery platform, Peptelligence, which is designed to extend the technology to small molecule therapeutics. Enteris recently acquired the Peptelligence platform, along with nasal delivery technology and a recombinant manufacturing process for therapeutic peptides, from Unigene Laboratories.   In conjunction with the launch, Enteris has appointed Brian Zietsman as president and chief financial officer, Nozer Mehta, Ph.D., as chief sc...